I apologize for the delay in our response. FDA does not have specific guidance that addresses a study close out visit or data queries. The activities a sponsor, CRO and investigator/site follow for a close out visit and any data query follow-up are usually addressed in Standard Operating Procedures (SOPs) of the sponsor, CRO, and site. The following is advisement that we have provided in the past: